SCHEMBL4591593

SCHEMBL4591593

O=C(O)CON1C(=O)C=CC1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 5/20 0.38
PTGS2 P35354 5/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 1/20 0.38
ALOX15 P16050 1/20 0.35
HPGD P15428 1/20 0.35
CYP2C19 P33261 1/20 0.35
BLM P54132 1/20 0.35
WRN Q14191 1/20 0.35
HIF1A Q16665 1/20 0.35
GSK3A P49840 1/20 0.34
GSK3B P49841 1/20 0.34
TSHR P16473 1/20 0.33
CTH P32929 1/20 0.33
CBS P35520 1/20 0.33
THPO P40225 1/20 0.33
DDAH1 O94760 1/20 0.32
NSD2 O96028 1/20 0.32
G6PD P11413 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20387844 0.75 ALDH1A1 (0.35) ALDH1A1CYP1A2CYP2C9HPGDCYP2C19
SCHEMBL9516281 0.74 ALDH1A1 (0.33) ALDH1A1CYP1A2HPGDCYP2C19BLM
SCHEMBL31121822 0.74 ALDH1A1 (0.34) PTGS1PTGS2ALDH1A1CYP1A2ALOX15
SCHEMBL28933285 0.73 ALOX12 (0.42) ALDH1A1CYP1A2CYP2C9ALOX15HPGD
SCHEMBL14789765 0.72 ALDH1A1 (0.37) ALDH1A1CYP1A2HPGDCYP2C19BLM
SCHEMBL9315522 0.71 ALDH1A1 (0.45) ALDH1A1CYP1A2CYP2C9ALOX15TSHR
SCHEMBL169531 0.70 MGLL (0.37) ALDH1A1CYP1A2HPGDCYP2C19BLM
Acetic Acid SCHEMBL7097518 0.70 ALDH1A1 (0.34) PTGS1PTGS2ALDH1A1CYP1A2HPGD
SCHEMBL31121818 0.70 ALDH1A1 (0.37) PTGS1PTGS2ALDH1A1CYP1A2HPGD
SCHEMBL15892773 0.69 MGLL (0.35) ALDH1A1CYP1A2HPGDCYP2C19BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442485-B2 Lithographic process involving on press development FUJIFILM CORPORATION (JP) 2008-10-28 US disclosed
EP-1484177-B1 Lithographic process involving on press development FUJIFILM CORP (JP) 2007-08-29 EP disclosed
US-20050016402-A1 Lithographic process involving on press development FUJI PHOTO FILM CO., LTD. 2005-01-27 US disclosed
EP-1484177-A2 Lithographic process involving on press development FUJI PHOTO FILM CO., LTD. (JP) 2004-12-08 EP disclosed
EP-0911323-A1 Biologically useful conjugates MALLINCKRODT, INC. (US) 1999-04-28 EP disclosed
EP-0455268-B1 Biologically useful conjugates MALLINCKRODT INC (US) 1999-04-07 EP disclosed
EP-0178125-B1 Labeled antibody fragments. Mallinckrodt, Inc. (a Delaware corporation) (US) 1992-08-12 EP disclosed
EP-0455268-A1 Biologically useful conjugates MALLINCKRODT, INC. (US) 1991-11-06 EP disclosed
EP-0174853-B1 RADIOLABELED ANTIBODY FRAGMENTS Mallinckrodt, Inc. (a Delaware corporation) (US) 1990-07-11 EP disclosed
EP-0350972-A2 Radiolabeled antibody fragments Mallinckrodt, Inc. (a Delaware corporation) (US) 1990-01-17 EP disclosed
US-4837003-A RADIONUCLIDE-ANTIBODY CHELATE COMPLEX; TUMOR DIAGNOSIS MALLINCKRODT, INC. (US) 1989-06-06 US disclosed
US-4659839-A MALEIMIDE AND CHELATING MOIETY MALLINCKRODT, INC. (US) 1987-04-21 US disclosed
EP-0178125-A2 Labeled antibody fragments. Mallinckrodt, Inc. (a Delaware corporation) (US) 1986-04-16 EP disclosed
EP-0174853-A2 Radiolabeled antibody fragments Mallinckrodt, Inc. (a Delaware corporation) (US) 1986-03-19 EP disclosed